HERON THERAPEUTICS INC (HRTX)

US4277461020 - Common Stock

2.34  +0.02 (+0.86%)

After market: 2.35 +0.01 (+0.43%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
127.04M107.70M86.30M88.60M146.00M
Cost Of Goods
65.11M54.90M46.00M36.20M61.60M
Gross Profit
61.94M52.80M40.30M52.40M84.30M
Operating Expenses
172.55M227.40M258.20M280.60M295.10M
Research and Development
55.90M107.50M130.80M174.50M167.40M
Selling, General, and Administrative Expenses
116.66M120.00M127.30M106.10M127.70M
Operating Income
-110.61M-174.70M-217.80M-228.20M-210.70M
Interest Income/Expense
-504.00K-800.00K-2.00M1.70M5.80M
Other Income/Expense
560.00K-6.50M-900.00K-800.00K200.00K
Income Before Taxes
-110.56M-182.00M-220.70M-227.30M-204.70M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-110.56M-182.00M-220.70M-227.30M-204.70M
EBITDA
-107.72M-171.81M-214.78M-225.35M-208.66M
 
Per Share Data
EPS Diluted Total Ops
-0.80-1.67-2.24-2.50-2.50
Non GAAP EPS
-0.86-1.73-2.25-2.50-2.50
 
Statistics
Gross Profit Margin
48.75%49.03%46.70%59.14%57.74%
Profit Margin
-87.02%-168.99%-255.74%-256.55%-140.21%
Operating Profit Margin
-87.07%-162.21%-252.38%-257.56%-144.32%

All data in USD

Charts